Abstract
Background & Aims Multisystem inflammatory syndrome in children (MIS-C) is a rare, but severe complication of coronavirus disease 2019, commonly involving the gastrointestinal tract. Some children with MIS-C undergo appendectomy before the final diagnosis. There are several hypotheses explaining pathomechanism of MIS-C, with the central role of the viral antigen persistence in the gut, associated with lymphocyte exhaustion and immune system dysregulation. We aimed to examine appendectomy specimens obtained from MIS-C patients and analyze the pathological features of the disease and the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens in the appendix.
Methods In this cross-sectional study we included 21 children with MIS-C who underwent appendectomy before the final diagnosis. MIS-C patients were recruited from the Polish national registry of inflammatory syndromes in children. The control group included 21 sex- and age-matched children with acute appendicitis (AA) unrelated to SARS-CoV-2 infection. Histological evaluation involved hematoxylin and eosin staining and immunohistochemical identification of lymphocyte subpopulations, programmed cell death protein 1, and SARS-CoV-2 nucleocapsid antigen.
Results Appendices of MIS-C patients lacked neutrophilic infiltrate of muscularis propria typical for AA (14 vs 95%, p<0.001). The proportion of CD20+ to CD5+ cells was higher in patients with MIS-C (p 0.04), as well as the proportion of CD4+ to CD8+ (p <0.001). We found no proof of SARS-CoV-2 antigen presence, nor lymphocyte exhaustion, in the appendices of MIS-C patients.
Conclusions Our findings describe pathomorphological features of the appendix in MIS-C and argue against the central role of SARS-CoV-2 persistence in the gut and concomitant lymphocyte exhaustion as the major triggers of MIS-C.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Sources of funding: The Polish National Agency for Academic Exchange (NAWA) grant BPN/GIN/2021/1/00031 Medical University of Warsaw, Department of Pediatrics with Clinical Assessment Unit Medical University of Warsaw, Department of Pathology
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Bioethical Committee of Medical University of Warsaw (Approval No: KB/135/2021).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Location of department and institution where the work was performed: 1. Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, 61 Zwirki i Wigury Street, 02-091, Warsaw, Poland. 2. Department of Pathology, Medical University of Warsaw, 7 Pawińskiego Street, 02-106, Warsaw, Poland
Grant support
Sources of funding: The Polish National Agency for Academic Exchange (NAWA) grant BPN/GIN/2021/1/00031 Medical University of Warsaw, Department of Pediatrics with Clinical Assessment Unit Medical University of Warsaw, Department of Pathology The study sponsors had no role in the study design, the collection, analysis, or interpretation of the study data.
Disclosures The authors have no conflicts of interest to declare.
Weronika Woźniak: conceptualization, investigation, methodology, project administration, resources, writing – original draft
Joanna Mańdziuk: investigation, writing – original draft
Kamila Maria Ludwikowska: conceptualization, resources, writing – original draft
Wojciech Feleszko: conceptualization, funding acquisition, writing – original draft
Jakub Grzybowski: methodology, investigation, formal analysis, writing – original draft
Mariusz Panczyk: methodology, formal analysis, writing – original draft
Elżbieta Berdej-Szczot: resources, writing – original draft
Janusz Zaryczański: resources, writing – original draft
Barbara Górnicka: funding acquisition, resources, writing – review & editing
Leszek Szenborn: investigation, writing – review & editing
Ernest Kuchar: funding acquisition, investigation, writing – review & editing
Data Transparency Statement Data and analytic methods will be made available to other researchers upon request.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- AA
- (acute appendicitis)
- BMI
- (body mass index)
- BNP
- (B-type natriuretic peptide)
- COVID-19
- (coronavirus disease 2019)
- H&E
- (hematoxylin and eosin)
- HR
- (heart rate)
- INR
- (international normalized ratio)
- IVIG
- (intravenous immunoglobulin)
- LVEF
- (left ventricular ejection fraction)
- MIS-C
- (multisystem inflammatory syndrome in children)
- MOIS-CoR
- (the MultiOrgan Inflammatory Syndromes Covid Related)
- NT-proBNP
- (N-terminal prohormone of B-type natriuretic peptide)
- PCR
- (polymerase chain reaction)
- PCT
- (procalcitonin)
- PD-1
- (programmed cell death 1 protein)
- PICU
- (pediatric intensive care unit)
- SARS-CoV-2
- (severe acute respiratory syndrome coronavirus 2)
- sBP
- (systolic blood pressure)
- Tfh
- (T follicular helper cells)
- WBC
- (white blood cells)
- WHO
- (World Health Organization)
